Heather Kiessling Sells 23,124 Shares of ASP Isotopes (NASDAQ:ASPI) Stock

ASP Isotopes Inc. (NASDAQ:ASPI) CFO Heather Kiessling sold 23,124 shares of the company’s stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $6.28, for a total value of $145,218.72. Following the completion of the sale, the chief financial officer owned 1,526,252 shares in the company, valued at $9,584,862.56. The trade was a 1.49% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Heather Kiessling also recently made the following trade(s):

• On Wednesday, April 15th, Heather Kiessling sold 23,124 shares of ASP Isotopes stock. The shares were sold at an average price of $5.48, for a total value of $126,719.52.

ASP Isotopes Stock Performance

ASP Isotopes stock opened at $5.63 on Friday. ASP Isotopes Inc. has a 12 month low of $3.92 and a 12 month high of $14.49. The company has a market capitalization of $708.82 million, a price-to-earnings ratio of -2.71 and a beta of 3.51. The business’s fifty day simple moving average is $6.26 and its two-hundred day simple moving average is $5.90. The company has a current ratio of 4.39, a quick ratio of 4.37 and a debt-to-equity ratio of 0.69.

ASP Isotopes (NASDAQ:ASPI) last issued its quarterly earnings results on Wednesday, May 20th. The company reported ($0.22) earnings per share for the quarter, beating the consensus estimate of ($0.28) by $0.06. The firm had revenue of $8.36 million during the quarter, compared to the consensus estimate of $3.68 million. ASP Isotopes had a negative return on equity of 112.46% and a negative net margin of 644.40%.

Wall Street Analysts Forecast Growth

ASPI has been the subject of a number of analyst reports. Canaccord Genuity Group restated a “buy” rating and set a $11.00 price objective on shares of ASP Isotopes in a research note on Tuesday, April 14th. Weiss Ratings reiterated a “sell (d-)” rating on shares of ASP Isotopes in a report on Wednesday, June 24th. Two equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $13.00.

Institutional Trading of ASP Isotopes

A number of hedge funds have recently bought and sold shares of ASPI. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in ASP Isotopes by 9.4% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 31,613 shares of the company’s stock valued at $148,000 after acquiring an additional 2,709 shares during the period. Rhumbline Advisers grew its stake in shares of ASP Isotopes by 20.9% during the 2nd quarter. Rhumbline Advisers now owns 78,994 shares of the company’s stock valued at $581,000 after purchasing an additional 13,668 shares during the period. XTX Topco Ltd purchased a new stake in shares of ASP Isotopes during the 2nd quarter valued at about $178,000. New York State Common Retirement Fund lifted its stake in shares of ASP Isotopes by 418.2% in the 2nd quarter. New York State Common Retirement Fund now owns 17,100 shares of the company’s stock worth $126,000 after purchasing an additional 13,800 shares during the period. Finally, Invesco Ltd. boosted its holdings in shares of ASP Isotopes by 2,205.0% in the second quarter. Invesco Ltd. now owns 471,219 shares of the company’s stock worth $3,468,000 after buying an additional 450,776 shares during the last quarter. Hedge funds and other institutional investors own 16.80% of the company’s stock.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.